BRIEF published on 05/29/2024 at 13:55, 3 months 22 days ago ZTEST Electronics Inc. Reports Record Nine-Month Financial Results Financial Results EBITDA Revenue Growth Net Income Customer Base
PRESS RELEASE published on 05/29/2024 at 13:50, 3 months 22 days ago ZTEST Announces Record Nine Month Financial Results ZTEST Electronics Inc. announces record revenue and net income for nine months ending March 31, 2024. Achieved 78% increase in revenue and $1,207,651 in net income. EBITDA grew 794% to $1,729,060 Financial Results EBITDA Net Income Record Revenue ZTEST Electronics Inc.
BRIEF published on 04/24/2024 at 13:35, 4 months 26 days ago ZTEST Electronics Inc. Announces Board Appointment Board Of Directors Corporate Governance ZTEST Electronics Inc. Audit Committee Corporate Appointment
BRIEF published on 04/24/2024 at 13:35, 4 months 26 days ago ZTEST Electronics Inc. annonce une nomination au conseil d'administration Conseil D'administration Gouvernance D'Entreprise Comité De Vérification ZTEST Électronique Inc. Rendez-vous Corporatif
PRESS RELEASE published on 04/24/2024 at 13:30, 4 months 26 days ago ZTEST Appoints Bill Johnstone as Director ZTEST Electronics Inc. appoints William R. Johnstone to the Board of Directors, thanking Donald Beaton. Johnstone brings 40 years of corporate and securities law experience Board Of Directors Corporate Secretary ZTEST Electronics Inc. Securities Law William R. Johnstone
BRIEF published on 04/05/2024 at 23:26, 5 months 15 days ago ZTEST Electronics Increases Private Placement to $1.25 Million Amid High Demand Private Placement Non-brokered Electronic Manufacturing Services Working Capital Units ZTEST Electronics
BRIEF published on 04/05/2024 at 23:26, 5 months 15 days ago ZTEST Electronics augmente son placement privé à 1,25 million de dollars dans un contexte de forte demande Placement Privé Services De Fabrication Électronique ZTEST Électronique Unités De Fonds De Roulement Sans Courtier
PRESS RELEASE published on 04/05/2024 at 23:21, 5 months 15 days ago ZTEST Announces Over-Subscription and Increase of Non-Brokered Private Placement to $1.25 Million ZTEST Electronics Inc. increases non-brokered private placement to $1,250,000 to meet demand. Offering includes 5,000,000 working capital units at $0.25 Private Placement Investment Non-brokered ZTEST Electronics Inc. Working Capital Units
BRIEF published on 04/05/2024 at 13:35, 5 months 15 days ago ZTEST annonce un placement privé sans intermédiaire de 500 000 $ Investissement Placement Privé Fonds De Roulement ZTEST Électronique Inc. Services De Fabrication Électronique
BRIEF published on 04/05/2024 at 13:35, 5 months 15 days ago ZTEST Announces $500,000 Non-Brokered Private Placement Private Placement Working Capital Investment ZTEST Electronics Inc. Electronic Manufacturing Services
Published on 09/20/2024 at 23:40, 2 hours 10 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 2 hours 20 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 2 hours 50 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 3 hours 20 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 3 hours 35 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 2 hours 51 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 4 hours 50 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 5 hours 35 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 6 hours ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 6 hours 3 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 8 hours 10 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 8 hours 10 minutes ago Mise à disposition du Rapport Financier Semestriel 2024